LeMaitre Vascular, Inc. To Sell Direct-To-Hospital In Australia And Norway

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass., Jan. 2, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it has begun selling Direct-to-Hospital in Australia and Norway in January 2014.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC